AnalystsLisa WalterLisa Walter's Stock Forecasts
AnalystsLisa Walter
Sectors:
Industries:
Analyst Ranking
Top 24%
#1319 out of 5511 analysts
Average Return
+6.33%
Win Rate
51%18 out of 35
Risk vs Reward
Poor
Good
Lisa Walter's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Opus Genetics IncIRD | +59.02% | $3.66 | $5.82 | 2026-08-07 - 2026-09-15 | Buy |
Viridian Therapeutics IncVRDN | +56.38% | $13.96 | $21.83 | 2026-04-07 - 2026-09-15 | Buy |
Meiragtx Holdings PLCMGTX | +55.80% | $8.19 | $12.76 | 2025-11-14 - 2026-09-15 | Buy |
4d Molecular Therapeutics IncFDMT | +51.78% | $8.98 | $13.63 | 2026-03-19 - 2026-09-15 | Buy |
Eyepoint IncEYPT | +46.20% | $8.81 | $12.88 | 2025-06-17 - 2026-06-16 | Buy |
Lisa Walter Analyst Color
Get additional color on Lisa Walter's coverage of popular stocks
Lisa Walter's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Eyepoint IncEYPT | 4 | Hold | $5.00 | +36.61% | Downgrades | a month ago |
Meiragtx Holdings PLCMGTX | 5 | Buy | $27.00 | +111.60% | Maintains | a month ago |
Krystal Biotech IncKRYS | 1 | Buy | $400.00 | +18.81% | Initiates Coverage On | a month ago |
Viridian Therapeutics IncVRDN | 7 | Buy | $36.00 | +64.91% | Maintains | a month ago |
Opus Genetics IncIRD | 1 | Buy | $9.00 | +54.64% | Maintains | a month ago |
United Therapeutics CorpUTHR | 6 | Buy | $677.00 | +35.31% | Maintains | a month ago |
Mirum Pharmaceuticals IncMIRM | 3 | Buy | $135.00 | +43.77% | Maintains | a month ago |
Rhythm Pharmaceuticals IncRYTM | 5 | Buy | $155.00 | +60.17% | Maintains | a month ago |
Ocular Therapeutix IncOCUL | 1 | Buy | $30.00 | +194.41% | Reiterates | 4 months ago |
4d Molecular Therapeutics IncFDMT | 3 | Buy | $35.00 | +156.79% | Maintains | 6 months ago |
Apellis Pharmaceuticals IncAPLS | 2 | Hold | $21.00 | -48.82% | Maintains | 7 months ago |
Adverum Biotechnologies IncADVM | 1 | Hold | $4.00 | -8.26% | Maintains | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.